Literature DB >> 16384964

Mutated mouse and human myocilins have similar properties and do not block general secretory pathway.

Irina Malyukova1, Hee-Sheung Lee, Robert N Fariss, Stanislav I Tomarev.   

Abstract

PURPOSE: The present study compared properties of wild-type and mutated mouse and human myocilin (Myoc) proteins as a prerequisite for development of a mouse model of glaucoma.
METHODS: cDNA encoding full-length mouse Myoc was cloned into the p3XFLAG-CMV-14 vector. Tyr423His and Ile463Ser mutations were introduced into the mouse Myoc protein by in vitro mutagenesis. Intracellular localization and secretion of wild-type and mutated mouse Myoc proteins were studied in immunostaining and Western blotting experiments, respectively, after transfection into COS-7 cells.
RESULTS: Similar to human MYOC, wild-type and mutated mouse Myoc demonstrated vesicular staining in transfected cells. However, while wild-type human and mouse Myoc were preferentially located in both the endoplasmic reticulum and Golgi, mutated human and mouse Myoc were located mainly in the endoplasmic reticulum and were excluded from Golgi. Similar to mutations in human MYOC, mutations in mouse Myoc dramatically reduced its secretion from transfected cells. Secretion of mutated Myoc was partially restored by culturing cells at 30 degrees C instead of 37 degrees C. The presence of mutated human MYOC prevented secretion of wild-type mouse Myoc but did not dramatically affect secretion of alkaline phosphatase, thrombospondin, Timp3 or olfactomedin-1.
CONCLUSIONS: Properties of the mouse Myoc protein are similar to those of the human MYOC. The presence of mutated mouse or human Myoc does not block a general secretory pathway. Expression of mutated Myoc in the eye in mice may mimic human glaucoma and lead to development of a genetic mouse model of glaucoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16384964     DOI: 10.1167/iovs.05-0220

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Yiming Wang; Iramofu M Dominic; Carol K Hall; Raquel L Lieberman
Journal:  Biochemistry       Date:  2019-03-12       Impact factor: 3.162

2.  Myocilin regulates cell proliferation and survival.

Authors:  Myung Kuk Joe; Heung Sun Kwon; Radu Cojocaru; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

3.  Olfactomedin 2: expression in the eye and interaction with other olfactomedin domain-containing proteins.

Authors:  Afia Sultana; Naoki Nakaya; Vladimir V Senatorov; Stanislav I Tomarev
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-20       Impact factor: 4.799

4.  Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex.

Authors:  Myung Kuk Joe; Changwon Kee; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2012-02-25       Impact factor: 5.157

5.  Expression of myocilin mutants sensitizes cells to oxidative stress-induced apoptosis: implication for glaucoma pathogenesis.

Authors:  Myung Kuk Joe; Stanislav I Tomarev
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

6.  Optimedin induces expression of N-cadherin and stimulates aggregation of NGF-stimulated PC12 cells.

Authors:  Hee-Sheung Lee; Stanislav I Tomarev
Journal:  Exp Cell Res       Date:  2006-09-28       Impact factor: 3.905

7.  Myocilin, a glaucoma-associated protein, promotes cell migration through activation of integrin-focal adhesion kinase-serine/threonine kinase signaling pathway.

Authors:  Heung Sun Kwon; Stanislav I Tomarev
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

8.  Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling.

Authors:  Heung Sun Kwon; Thomas V Johnson; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

9.  Myocilin is a modulator of Wnt signaling.

Authors:  Heung-Sun Kwon; Hee-Sheung Lee; Yun Ji; Jeffrey S Rubin; Stanislav I Tomarev
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

10.  Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.

Authors:  Heung Sun Kwon; Naoki Nakaya; Mones Abu-Asab; Hong Sug Kim; Stanislav I Tomarev
Journal:  J Neurosci       Date:  2014-04-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.